Dr. Christopher Thomas Stokoe, MD

  • Plano, TX
  • Medical oncologist
NPI1801839758PAC ID6103729413
Medicare services, 2024
53,084
Medicare patients, 2024
839
Part D claims, 2024
1,110
Publications
7
Clinical trials
10
Practice address
3705 W 15th St, Plano, TX 75075
Practice phone
Call (972) 997-8000
Professional email
Get professional email
Personal email
Get personal email
Mobile number
Get mobile number
Social profiles

Primary practice

Texas Oncology PA

Plano, Texas

See all 10 affiliations

Find Dr. Stokoe's professional email, personal email and mobile number

Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.

View contacts for free

Dr. Christopher Thomas Stokoe is a medical oncologist in Plano, Texas

Dr. Stokoe practices at Texas Oncology PA in Plano, Texas.

Dr. Stokoe's NPI, 1801839758, was assigned on June 14, 2006. Dr. Stokoe graduated from University of Texas Medical Branch School of Medicine in 1996. Dr. Stokoe holds Texas license K2805.

NPI and contact details
Medicare PAC ID
6103729413
NPI enumeration date
June 14, 2006
NPI status
Active
Accepts Medicare assignment
Yes
Offers telehealth
Yes
Practice phone
(972) 997-8000
Professional email
Get email
Personal email
Get email
Mobile number
Get number
Sex
Male
Estimated age
56
Medical school graduation
1996

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Practice Data; and Doctors and Clinicians National Downloadable File (CMS)

Dr. Christopher Thomas Stokoe practices at Texas Oncology PA in Plano, Texas

Dr. Stokoe's primary practice is Texas Oncology PA, at 3705 W 15th St, Plano, TX 75075 in Collin County. The practice phone is (972) 997-8000.

  • Texas Oncology PA
    3705 W 15th St, Plano, TX 75075 · Collin CountyPhone(972) 997-8000

Sources: NPPES NPI Registry (CMS); and Dmand AI Practice Data

Dr. Christopher Thomas Stokoe is affiliated with 9 sites of care and 1 medical group

Dr. Stokoe's primary practice is Texas Oncology PA in Plano, Texas. Dr. Stokoe is also affiliated with Medical City Plano Hospital. The medical group on file is Texas Oncology. Dmand AI also links Dr. Stokoe to 5 more hospitals, 1 group practice or clinic and 1 home health agency, each named with a free account.

See all 10 affiliations for Dr. Stokoe

Sources: NPPES NPI Registry (CMS); Dmand AI Practice Data; and Dmand AI Affiliation Data

Dmand AI tracks the EHR system at Dr. Christopher Thomas Stokoe's practice

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Stokoe practices, 8 sites in all. Vendor and product names are available with a free account.

EHR by site
SiteEHR vendor and product
Texas Oncology PAAvailable with a free account
+8 more affiliated sitesAvailable with a free account

Source: Dmand AI Technology Install Data

For health IT teams

See the EHR and IT leaders at every site where Dr. Stokoe practices

Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.

Dr. Christopher Thomas Stokoe is one of 484 medical oncologists in Texas

Medical oncology is Dr. Stokoe's primary specialty in the NPI Registry, under taxonomy code 207RX0202X. Dr. Stokoe is board certified in medical oncology by the American Board of Internal Medicine. Dr. Stokoe is licensed in Texas.

Specialties and state licenses

  • Medical oncology, TexasPrimaryLicense K2805 · 1997 to 2027 · taxonomy 207RX0202X

Clinical focus

Dmand AI lists breast cancer, chronic anemia, chronic leukemia, colorectal cancer, lung cancer, lymphoma, multiple myeloma and prostate cancer among the conditions Dr. Stokoe treats.

Medical oncologists near Dr. Stokoe

Counts of medical oncologists with a Dmand AI profile, by place and practice. Each opens the list.

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks

Dr. Christopher Thomas Stokoe billed Medicare for 53,084 services in 2024

CMS data shows 53,084 Medicare services from Dr. Stokoe across 56 procedure codes in 2024, for 839 Medicare patients. Medicare paid $722,950 for them.

Medicare services, 202453,084
Medicare patients839
Paid by Medicare$722,950
Procedure codes56

Dr. Stokoe's Medicare services by type, 2023 to 2024

  • 2023
  • 2024
Drugs given in the office
2023: 43,5652024: 38,53212%
Other services
2023: 6,9892024: 8,52722%
Lab and pathology
2023: 3,0862024: 2,8448%
Tests and treatments
2023: 1,1272024: 1,0903%
Surgery
2023: 1,0402024: 9578%
Office and hospital visits
2023: 8102024: 8525%
Imaging
2023: 3272024: 28214%

Where Dr. Stokoe's Medicare services took place, 2024

  • In an office53,066100%
  • In a facility180%

Dr. Stokoe compared with the Texas median for medical oncologists, 2024

  • Dr. Stokoe
  • Texas median
Medicare services
53,084vs 73672.1 times
Medicare patients
839vs 2004.2 times
Part D claims
852vs 3342.6 times

Medians across 448 medical oncologists in Texas with Dmand AI profiles that report each measure.

Dr. Stokoe's most billed Medicare procedure codes, 2024

CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.

See all procedures by Dr. Stokoe

Need commercial claims for Dr. Stokoe?

Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Stokoe and other medical oncologists in Texas.

Book a meeting

Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks

Dr. Christopher Thomas Stokoe treated 839 Medicare patients in 2024, average age 76

CMS counts 839 Medicare patients who saw Dr. Stokoe in 2024. The largest group is 75 to 84, with 385 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 4% are also on Medicaid. Their average risk score is 1.68, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Stokoe's median patient age at 70, with 78% women.

Medicare patients, 2024839
Average age76
Average risk score1.68
Also on Medicaid4%

Dr. Stokoe's Medicare patients by age, 2024

Dr. Stokoe's Medicare patients by sex, 2024

  • Women60872%
  • Men23128%

Chronic conditions among Dr. Stokoe's Medicare patients, 2024

  1. High blood pressure75%
  2. High cholesterol75%
  3. Cancer64%
  4. Arthritis49%
  5. Chronic kidney disease29%
  6. Diabetes29%
  7. Ischemic heart disease29%
  8. Anxiety25%

Share of Medicare patients with each condition. A patient can have several.

Dr. Stokoe's patients across all payers

Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.

Patient panel by age, all payers

Median age 70

Patient panel by sex, all payers

  • Women78%
  • Men19%

Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data

Dr. Christopher Thomas Stokoe wrote 1,110 Medicare Part D claims in 2024

In 2024, Dr. Stokoe wrote 1,110 Medicare Part D claims for 247 patients. 85% of them were for generic drugs. CMS names the drug for 852 of them, across 29 drugs with 11 or more claims each, at $1,019,801 in total drug cost. In 2023, CMS named 913 claims across 27 drugs.

Part D claims, 20241,110
Drugs named by CMS29
Total drug cost$1M
Part D patients247

Dr. Stokoe's Part D claims by kind of drug, 2024

  • Generic942 claims85%
  • Brand-name168 claims15%

Dr. Stokoe's most prescribed drugs by claims, 2024

CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.

Drug classes CMS tracks in Dr. Stokoe's Part D claims, 2024

  • Opioids10%113 of 1,110 claims
  • Antibiotics3%31 of 1,110 claims

Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.

Part D claims for drugs CMS names, 2023 to 2024

  • 2023
  • 2024
Claims for drugs CMS names
2023: 9132024: 8527%

Drugs named by CMS: 29 in 2024, 27 in 2023.

See all prescribing by Dr. Stokoe

Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data

Dr. Christopher Thomas Stokoe scored 85 out of 100 in Medicare's MIPS program for 2024

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 85 out of 100 for Dr. Stokoe for performance year 2024, reported through an alternative payment model (APM). Dr. Stokoe accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Stokoe as offering telehealth.

Accepts Medicare assignment
Yes
Offers telehealth
Yes

Dr. Stokoe's MIPS scores, performance year 2024

  • 85of 100Final score
  • 67.5of 100Quality
  • 100of 100Promoting Interoperability
  • 40of 100Improvement Activities

Each score is out of 100. The final score weighs the categories CMS scored for this clinician.

Sources: Doctors and Clinicians National Downloadable File (CMS); and Clinician Public Reporting: Overall MIPS Performance (CMS), 2024 data, released September 10, 2026

For MedTech and pharma teams

Find medical oncologists like Dr. Stokoe by procedure volume and prescribing

Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.

Dr. Christopher Thomas Stokoe has 7 publications on record

Dmand AI links 7 papers to Dr. Stokoe, published from 2013 to 2021. 2015 was the busiest year, with 2. The most frequent topics are Antineoplastic Combined Chemotherapy Protocols, Breast Neoplasms and Chemotherapy, Adjuvant. Dr. Stokoe's most frequent co-authors are Joyce Ann O'Shaughnessy, MD, Joanne Lorraine Blum, MD and Virginia F. Borges, MD.

Papers7
Years published2013 to 2021

Dr. Stokoe's papers by year, 2013 to 2021

Topics Dr. Stokoe writes about most

  • Antineoplastic Combined Chemotherapy Protocols
  • Breast Neoplasms
  • Chemotherapy, Adjuvant
  • Cyclophosphamide
  • Docetaxel
  • Doxorubicin
  • Receptor, ErbB-2
  • Taxoids

Dr. Stokoe's most frequent co-authors

Recent publications by Dr. Stokoe

See all 7 publications and co-authors

See who Dr. Stokoe researches with

Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Stokoe works with, so you can find a warm path to the right medical oncologists.

How network discovery works

Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage

Dr. Christopher Thomas Stokoe has worked on 10 clinical trials

Dmand AI links Dr. Stokoe to 10 clinical trials, 3 of them phase 2 studies. 4 are still active or recruiting. Conditions studied include Breast Neoplasms, Breast Diseases and Brain Neoplasms. Eli Lilly and Company sponsors the most, 3. Open Payments lists research payments to Dr. Stokoe that name 2 trials.

Clinical trials with Dr. Stokoe by phase

  1. NonePhase 1: no trials
  2. 3Phase 2: 3 trials
  3. 2Phase 3: 2 trials
  4. NonePhase 4: no trials

Conditions in Dr. Stokoe's trials

  • Breast Neoplasms
  • Breast Diseases
  • Brain Neoplasms
  • Hereditary Sensory and Autonomic Neuropathies
  • Neoplasm Metastasis

Investigators on the most trials with Dr. Stokoe

Recent clinical trials with Dr. Stokoe

See all 10 clinical trials and co-investigators

Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)

Dr. Christopher Thomas Stokoe received $89,260 in industry payments from 2016 to 2025

CMS Open Payments shows 287 general payments to Dr. Stokoe from 48 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 61% of the total. Puma Biotechnology, Inc. paid the most, $70,821. It also lists 3 research payments totaling $12,437 from 2018 to 2019, naming 2 clinical trials.

General payments to Dr. Stokoe by program year, 2016 to 2025

General payments to Dr. Stokoe by kind, 2016 to 2025

$89.3Kin total
  • Speaker and faculty fees$54,85061%
  • Consulting fees$23,63326%
  • Food and beverage$6,7638%
  • Travel and lodging$3,7864%
  • Education$2290%

Companies that paid Dr. Stokoe the most, 2016 to 2025

Share is of all general payments to this clinician.

See all payments to Dr. Stokoe

Source: Open Payments (CMS), 2025 data, released July 7, 2026

Dr. Christopher Thomas Stokoe has 1 award and honors on record

Dmand AI lists 1 award for Dr. Stokoe, most recently CMS Stage 1 2012 in 2012.

Awards and honors for Dr. Stokoe

  1. 2012
    • CMS Stage 1 2012

Source: Dmand AI Professional Profile Data

Dr. Christopher Thomas Stokoe graduated from University of Texas Medical Branch School of Medicine

Dr. Stokoe graduated from University of Texas Medical Branch School of Medicine in 1996.

  1. Medical schoolUniversity of Texas Medical Branch School of Medicine
  2. Board certified in medical oncologyAmerican Board of Internal Medicine
  3. Board certified in internal medicineNational Board of Physicians and Surgeons
  4. Board certified in medical oncologyNational Board of Physicians and Surgeons

Source: Dmand AI Professional Profile Data

Dr. Christopher Thomas Stokoe accepts plans from 24 insurance carriers

Dr. Stokoe is in network with 24 carriers, including Elevance, Aetna and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 15. Check the plan with the practice before a visit.

Plan types Dr. Stokoe accepts, by number of carriers

  1. PPO15
  2. HMO13
  3. Medicare12
  4. POS7
  5. EPO5
  6. Medicaid1

Source: Dmand AI Insurance Network Data

Sources for Dr. Christopher Thomas Stokoe's profile data

Sources for the data on this page
Data on this pageSource
NPI, name, sex, specialty and licensesNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data
Practice locations and phoneNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice Data
Primary practice, affiliations and health systemNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice DataDmand AI Affiliation Data
Medicare services and procedure codesMedicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab)
State medians for the same specialtyDmand AI Peer Benchmarks
Medicare patients and the all-payer patient panelDmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab)
Part D prescribingMedicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab)
MIPS scores, telehealth, assignment and procedure percentilesDoctors and Clinicians National Downloadable File (CMS) (opens in a new tab)Clinician Public Reporting: Overall MIPS Performance (CMS) (opens in a new tab)
Publications, topics and co-authorsPubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage
Clinical trials and co-investigatorsDmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab)
Industry paymentsOpen Payments (CMS) (opens in a new tab)
Awards and committee rolesDmand AI Professional Profile Data
Training, board certification and membershipsDmand AI Professional Profile Data
Insurance carriers and plan typesDmand AI Insurance Network Data
EHR at each practice siteDmand AI Technology Install Data
Similar physiciansDmand AI Affiliation Data

Data last refreshed October 2026Report an inaccuracyRemove my information

FAQ

Frequently asked questions about Dr. Christopher Thomas Stokoe

Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.

What is Dr. Christopher Thomas Stokoe's NPI number?

Dr. Christopher Thomas Stokoe's NPI number is 1801839758. It was assigned on June 14, 2006, and it is active in the NPI Registry.

What kind of doctor is Dr. Christopher Thomas Stokoe?

Dr. Christopher Thomas Stokoe is a medical oncologist in Plano, Texas. The primary specialty in the NPI Registry is Medical Oncology Physician (taxonomy code 207RX0202X).

Where does Dr. Christopher Thomas Stokoe practice?

Dr. Stokoe practices at 3705 W 15th St, Plano, TX 75075. Dr. Stokoe's primary practice is Texas Oncology PA in Plano, Texas. Dmand AI also links Dr. Stokoe to 5 hospitals, 1 group practice or clinic and 1 home health agency.

What is Dr. Christopher Thomas Stokoe's office phone number?

The practice phone on file for Dr. Stokoe is (972) 997-8000.

What is Dr. Christopher Thomas Stokoe's medical license number?

Dr. Stokoe holds Texas license K2805.

Which hospitals is Dr. Christopher Thomas Stokoe affiliated with?

Dr. Stokoe is affiliated with Medical City Plano Hospital. Dmand AI links Dr. Stokoe to 5 more hospitals.

What medical group is Dr. Christopher Thomas Stokoe part of?

Dr. Stokoe is linked to Texas Oncology.

Does Dr. Christopher Thomas Stokoe accept Medicare?

Yes. CMS data shows Dr. Stokoe billed Medicare for 53,084 services in 2024, and Dr. Stokoe accepts Medicare assignment.

Does Dr. Christopher Thomas Stokoe offer telehealth?

Yes. The CMS Doctors and Clinicians file lists Dr. Stokoe as offering telehealth services.

What is Dr. Christopher Thomas Stokoe's MIPS score?

Dr. Stokoe's MIPS final score for performance year 2024 is 85 out of 100, reported through an alternative payment model (APM).

Show 10 more questionsShow fewer questions

How many Medicare patients does Dr. Christopher Thomas Stokoe see?

CMS counts 839 Medicare patients who saw Dr. Stokoe in 2024, with an average age of 76.

Is Dr. Christopher Thomas Stokoe board certified?

Yes. Dr. Stokoe is board certified in medical oncology by the American Board of Internal Medicine.

What services does Dr. Christopher Thomas Stokoe bill to Medicare?

In 2024, Dr. Stokoe's most billed Medicare services were injected or infused drug (J1756), injected or infused drug (J0881) and medicare temporary code (Q9967).

Where did Dr. Christopher Thomas Stokoe go to medical school?

Dr. Stokoe graduated from University of Texas Medical Branch School of Medicine in 1996.

What drugs does Dr. Christopher Thomas Stokoe prescribe most?

In 2024 Medicare Part D data, Dr. Stokoe's most prescribed drugs by claims were Anastrozole, Letrozole and Gabapentin.

Has Dr. Christopher Thomas Stokoe received payments from drug or device companies?

CMS Open Payments shows $89,260 in general payments to Dr. Stokoe from 48 companies from 2016 to 2025. The largest total came from Puma Biotechnology, Inc.

How long has Dr. Christopher Thomas Stokoe been practicing?

Dr. Stokoe graduated from medical school in 1996, 30 years ago.

Does Dr. Christopher Thomas Stokoe do research?

Dmand AI links 7 publications to Dr. Stokoe, published from 2013 to 2021. Dr. Stokoe has worked on 10 clinical trials.

Who does Dr. Christopher Thomas Stokoe publish with?

Dr. Stokoe's most frequent co-authors are Joyce Ann O'Shaughnessy, MD (3 shared papers), Joanne Lorraine Blum, MD (2 shared papers) and Virginia F. Borges, MD (2 shared papers).

What insurance does Dr. Christopher Thomas Stokoe accept?

Dr. Stokoe is in network with 24 carriers, including Elevance, Aetna and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 15. Check the plan with the practice before a visit.

Selling to medical oncology practices?

See medical oncologists in Texas by site of care and group

Find the practices, groups and hospitals they work with, and the right people to contact at each.

  • 30 days free
  • Self-serve
  • No credit card

Cookie settings

Turn each category on or off. Your choice is kept for 12 months and you can change it here at any time.

Necessary

Always on. Sign-in, security, downloads you asked for, your cookie choice, and the page that led to a signup.

View cookies (6)
  • dm_consentDmand AI. Your cookie choices and whether your browser sent a Global Privacy Control signal. 12 months.
  • dm_ft, dm_ltDmand AI. The first and the latest page you arrived on, with the date, so a signup is credited to the page that worked. 90 days, 30 days.
  • dm_fs, dm_lsDmand AI. The first and the latest source of a visit (a search engine, a campaign or the site that linked here). 90 days, 30 days.
  • dm_dl, dm_dl_okDmand AI. After you give an email address for a download, lets you download files without being asked again. 30 days.
  • Session and CSRF cookiesDmand AI (app.dmand.ai). Sign-in and form protection in the application. Session.
  • __cf_bm, cf_clearanceCloudflare. Tells people from automated traffic and keeps the site available. 30 minutes; cf_clearance while a security check is valid.

Analytics

On unless you turn it off. How pages are used, in aggregate, and recordings of how pages are used.

View cookies (6)
  • Google Tag ManagerGoogle. Loads the analytics and marketing tags that are on. Sets no cookie of its own and does not load when both categories are off. n/a.
  • _ga, _ga_<container-id>Google Analytics 4. Visits and page views in aggregate on dmand.ai. 2 years.
  • _clck, _clskMicrosoft Clarity. Recordings and heatmaps of how pages are used, with form fields masked. 1 year, 1 day.
  • CLID, MUID, ANONCHK, MR, SMMicrosoft (clarity.ms). Set by Microsoft when Clarity loads, to recognize a browser across sites that use Clarity. Up to 1 year.
  • None (cookieless)Ahrefs Analytics. Page views in aggregate. n/a.
  • ph_<project>_posthogPostHog. Product usage, errors and performance in app.dmand.ai, used to fix bugs and improve features. 365 days.

Marketing

On unless you turn it off, and always off when your browser sends a Global Privacy Control signal. A visitor identification service tells our sales team which companies and people visit.

View cookies (6)
  • _reb2buid, _reb2butkRB2B. Recognizes a returning browser for visitor identification. 360 days, 1 year.
  • _reb2bgeoRB2B. The location used to decide whether a visit can be identified. 20 days.
  • _reb2brefRB2B. The page or site that referred the visit. 15 days.
  • _reb2bfxf, _reb2btd, _reb2bliRB2B. Links the visit to an identified business profile. 1 month.
  • _reb2bresolveRB2B. Holds a match while it is being resolved. 2 days.
  • _reb2sessionID, _reb2bloadedRB2B. The current visit, and a guard against loading the script twice. 30 minutes, 1 second.

Functional

On unless you turn it off. Remembers choices such as a collapsed section.

View cookies (none today)